InsidersTradesSigma
Total declarations
Company
▲ Purchases (28 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by CROCKER GARY L, Dirigeant. Insider active across 1 companies, notably Merrimack Pharmaceuticals INC. Aggregated, 28 filings have been published. Total volume traded: €437k. The latest transaction was disclosed on 9 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations28 total
€21,5824,452 shares@ €4.84764.9% of flow
Common Stock
SEC:0000899243-22-022153:0·
Ideal exit: 6 Mar 2023 (T+270)
€1,416300 shares@ €4.72020.3% of flow
Common Stock
SEC:0000899243-22-021612:0·
Ideal exit: 4 Mar 2023 (T+270)
€11,0062,323 shares@ €4.73792.5% of flow
Common Stock
SEC:0000899243-22-019682:0·
Ideal exit: 18 Feb 2023 (T+270)
€2,441512 shares@ €4.76680.6% of flow
Common Stock
SEC:0000899243-22-019200:0·
Ideal exit: 13 Feb 2023 (T+270)
€1,087225 shares@ €4.83090.2% of flow
Common Stock
SEC:0000899243-22-018778:0·
Ideal exit: 11 Feb 2023 (T+270)
€12,0012,471 shares@ €4.85662.7% of flow
Common Stock
SEC:0000899243-22-018126:0·
Ideal exit: 6 Feb 2023 (T+270)
€27,6895,000 shares@ €5.53776.3% of flow
Common Stock
SEC:0000899243-22-015556:0·
Ideal exit: 16 Jan 2023 (T+270)
€894161 shares@ €5.55460.2% of flow
Common Stock
SEC:0000899243-22-013091:0·
Ideal exit: 25 Dec 2022 (T+270)
€28,0355,000 shares@ €5.6076.4% of flow
Common Stock
SEC:0000899243-22-012692:0·
Ideal exit: 23 Dec 2022 (T+270)
€2,220400 shares@ €5.54930.5% of flow
Common Stock
SEC:0000899243-22-012077:0·
Ideal exit: 17 Dec 2022 (T+270)
€26,0944,649 shares@ €5.61296.0% of flow
Common Stock
SEC:0000899243-22-011381:0·
Ideal exit: 10 Dec 2022 (T+270)
€27,6075,000 shares@ €5.52156.3% of flow
Common Stock
SEC:0000899243-22-011037:0·
Ideal exit: 6 Dec 2022 (T+270)
€17,5693,351 shares@ €5.24294.0% of flow
Common Stock
SEC:0000899243-22-007378:0·
Ideal exit: 15 Nov 2022 (T+270)
€43,3507,945 shares@ €5.45629.9% of flow
Common Stock
SEC:0000899243-22-007005:0·
Ideal exit: 13 Nov 2022 (T+270)
€43,3507,945 shares@ €5.456235.0% of flow
Common Stock
SEC:0000899243-22-007005·
Ideal exit: 13 Nov 2022 (T+270)
€9,4361,800 shares@ €5.2422.2% of flow
Common Stock
SEC:0000899243-22-006627:0·
Ideal exit: 11 Nov 2022 (T+270)
€2,753673 shares@ €4.09120.6% of flow
Common Stock
SEC:0000899243-22-003632:0·
Ideal exit: 24 Oct 2022 (T+270)
€2,753673 shares@ €4.09122.2% of flow
Common Stock
SEC:0000899243-22-003632·
Ideal exit: 24 Oct 2022 (T+270)
€12,4923,100 shares@ €4.029510.1% of flow
Common Stock
SEC:0000899243-22-003422·
Ideal exit: 23 Oct 2022 (T+270)
€12,4923,100 shares@ €4.02952.9% of flow
Common Stock
SEC:0000899243-22-003422:0·
Ideal exit: 23 Oct 2022 (T+270)
€8,2292,000 shares@ €4.11436.6% of flow
Common Stock
SEC:0000899243-22-003136·
Ideal exit: 18 Oct 2022 (T+270)
€8,2292,000 shares@ €4.11431.9% of flow
Common Stock
SEC:0000899243-22-003136:0·
Ideal exit: 18 Oct 2022 (T+270)
€19,8855,000 shares@ €3.976916.1% of flow
Common Stock
SEC:0000899243-22-002634·
Ideal exit: 15 Oct 2022 (T+270)
€19,8855,000 shares@ €3.97694.6% of flow
Common Stock
SEC:0000899243-22-002634:0·
Ideal exit: 15 Oct 2022 (T+270)
€19,3335,000 shares@ €3.866715.6% of flow
Common Stock
SEC:0000899243-22-002118·
Ideal exit: 10 Oct 2022 (T+270)
25 of 28 declarations
About CROCKER GARY L
Gary L. Crocker is an insider at Merrimack Pharmaceuticals Inc.
